<DOC>
	<DOC>NCT00486200</DOC>
	<brief_summary>A study of ASP2151 in subjects with recurrent outbreaks of genital herpes.</brief_summary>
	<brief_title>A Study With ASP2151 in Subjects With Recurrent Episodes of Genital Herpes</brief_title>
	<detailed_description />
	<mesh_term>Herpes Genitalis</mesh_term>
	<mesh_term>Valacyclovir</mesh_term>
	<criteria>Subject has a history of genital HSV documented by laboratory testing at screening Subject has experienced 4 or more episodes of genital herpes during the past 12 months Subject is immunocompromised</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>Herpes Genitalis</keyword>
	<keyword>Herpes Simplex Virus Genital Infection</keyword>
	<keyword>Genital Herpes</keyword>
	<keyword>ASP2151</keyword>
	<keyword>Treatment Outcome</keyword>
	<keyword>Sexually Transmitted Disease</keyword>
</DOC>